WASHINGTON — A personalized alert triggered via the electronic health record during office visits resulted in more frequent prescription of guideline-directed medical therapies for patients with HF with reduced ejection fraction.
The EHR alerts also increased the rate of uptitration of currently prescribed HFrEF therapies, when the alert indicated that doing so may be beneficial, according to results of the PROMPT-HF trial, which were presented at the American College of Cardiology Scientific Session.
“We know that guideline-directed medical therapy improves clinical outcomes in